Merck & Co. Inc. (MRK)

84.53
0.15 0.18
NYSE : Health Technology
Prev Close 84.68
Open 84.97
Day Low/High 84.08 / 85.06
52 Wk Low/High 66.10 / 87.35
Volume 5.12M
Avg Volume 8.26M
Exchange NYSE
Shares Outstanding 2.56B
Market Cap 214.56B
EPS 2.30
P/E Ratio 39.53
Div & Yield 2.20 (2.59%)
Cramer: Got the Apple-FANG Blues? Look for a Rotation

Cramer: Got the Apple-FANG Blues? Look for a Rotation

There's one going on now.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

Cramer: August Finally Arrives

Cramer: August Finally Arrives

There are plenty of reasons for the selloff, not the least of which is White House chaos.

President Trump Has Disbanded His Manufacturing Council

President Trump Has Disbanded His Manufacturing Council

Pressure is mounting on CEOs to step down from President Donald Trump's American Manufacturing Council

CEOs Dump Donald Trump

CEOs Dump Donald Trump

CEOs exit President's Council after Charlottesville response

Daily Market Preview: CEOs Dump Trump & Activists Stir the Danone Pot

Daily Market Preview: CEOs Dump Trump & Activists Stir the Danone Pot

CEOs exit President's Council after Charlottesville response

North Korea Dials Down Tensions With United States, Stocks Higher

North Korea Dials Down Tensions With United States, Stocks Higher

North Korea says it will delay a decision on attacking Guam.

Rev's Forum: Bears' Fundamental Arguments Lose Out to Price Patterns

Rev's Forum: Bears' Fundamental Arguments Lose Out to Price Patterns

The problem for the pessimists is the same one that has plagued them since the election -- the price action is not cooperating.

Cramer: This Is Why You Keep Cash on Hand

Cramer: This Is Why You Keep Cash on Hand

Because the selloff isn't over.

President Trump Condemns Hate Groups, Days After Charlottesville Attack

President Trump Condemns Hate Groups, Days After Charlottesville Attack

Days after the deadly attack in Charlottesville, President Trump comes out with his strongest condemnation yet of the hate groups who rallied there.

Jim Cramer on Merck, Bitcoin, Nvidia, Netflix, Disney, Procter & Gamble, TJX and Home Depot

Jim Cramer on Merck, Bitcoin, Nvidia, Netflix, Disney, Procter & Gamble, TJX and Home Depot

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Monday's trending stocks.

Jim Cramer on Merck CEO Ken Frazier: Everyone Has a Right to Speak Their Mind

Jim Cramer on Merck CEO Ken Frazier: Everyone Has a Right to Speak Their Mind

Merck CEO Ken Frazier is leaving Trump's business council.

Cramer: FANG and the Lessons of History

Cramer: FANG and the Lessons of History

What a difference 2 years make -- or 17.

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly

Merck vs. Eli Lilly.

Jim Cramer on Amazon, Tesla, Starbucks, Exxon, Chevron, American Airlines, Southwest Airlines, Merck and Tax Reform

Jim Cramer on Amazon, Tesla, Starbucks, Exxon, Chevron, American Airlines, Southwest Airlines, Merck and Tax Reform

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Friday's trending stocks.

Does Merck's Rally Have Legs?

Does Merck's Rally Have Legs?

MRK has shaped up on the charts.

Cramer: Stop Talking About the 'Market'

Cramer: Stop Talking About the 'Market'

It just isn't as useful or descriptive right now.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

47 Quarterly Dividend Declared By Merck

47 Quarterly Dividend Declared By Merck

Merck , said today that its board of directors authorized a quarterly dividend of 47 cents

Cramer: Let Loose the Growth Hounds

Cramer: Let Loose the Growth Hounds

Day 2 of the selloff brings in an entirely new kind of buyer.

Closing Bell: Snap Sells Off After Weak Quarter; Macy's, Kohl's Sink Wall Street

Closing Bell: Snap Sells Off After Weak Quarter; Macy's, Kohl's Sink Wall Street

Stocks hold losses as a selloff in Snap pulls the rest of the tech sector lower.

Merck Ready to Resume Long-Term Uptrend

Merck Ready to Resume Long-Term Uptrend

The price momentum and money flow indicators of the drug maker are in positive alignment.

Blue-Chip Breakouts: Intel, Boeing, and Merck Are Ready to Spring Higher in May

Blue-Chip Breakouts: Intel, Boeing, and Merck Are Ready to Spring Higher in May

These three big stocks are teetering on the edge of breakout territory to start the month.

The Good, the Bad and the Ugly (Late Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have I might be trading some of the earnings reports that will be released ...

Wake Up Wall Street: Trump Considers Breaking Up Big Banks

Wake Up Wall Street: Trump Considers Breaking Up Big Banks

Trump suggested he could split their consumer businesses from investment operations

2 'Swing for the Fences' Small Biotechs

2 'Swing for the Fences' Small Biotechs

Genocea Biosciences and Eiger Biopharmaceuticals are high risk/high reward plays.

2 'Swing for the Fences' Small Biotechs

2 'Swing for the Fences' Small Biotechs

Genocea Biosciences and Eiger Biopharmaceuticals are high risk/high reward plays.

Surveying the NASH Drug Landscape

Surveying the NASH Drug Landscape

Biotech investors should keep a close eye on the progress in this huge potential market.

Takeaways and Observations (Early Edition)

"Doug Kass wrote an article today about how he fears the lack of fear in this market. I agree with Doug that lack of fear is an issue, but it goes further than that. What this market has missed for quite some time is strong emotion. There may not be...